Sign In
Get Clay Free →

Suggestions

    Stephen J. McAndrew, Ph.D.

    Vice President, Business Development at Sonnet BioTherapeutics, Inc.

    Dr. Stephen J. McAndrew is a highly accomplished executive with a proven track record in business development, strategic planning, and sales management across pharmaceutical and biotechnology sectors.

    He holds a Ph.D. in molecular/cellular biology, specializing in oncology and immunology/inflammation, providing him with comprehensive expertise in pharmaceutical drug discovery research.

    With extensive leadership experience, Dr. McAndrew has successfully initiated numerous research collaborations, partnerships, and licensing agreements, demonstrating exceptional negotiation skills with over 700 executed contracts.

    His core competencies include new business development, licensing, executive management, alliance management, and scientific drug discovery, among others, making him a sought-after professional in the industry.

    Throughout his career, Dr. McAndrew has held key positions at reputable organizations such as Sonnet BioTherapeutics, Oncobiologics, Taconic Biosciences, Caliper Life Sciences, Xenogen Corporation, and Lexicon Pharmaceuticals, showcasing his versatility and expertise in various aspects of the pharmaceutical business.

    His educational background includes a Ph.D. in Molecular & Cellular Biology from Ohio University, an MS in Yeast Genetics from the University at Albany, and a BS in Biology/Zoology from the State University of New York at Oswego.

    Dr. McAndrew's career highlights include originating significant intellectual property, driving innovative business opportunities, and maintaining a strong pharmaceutical and biotech network, positioning him as a key player in the industry.

    Stephen J. McAndrew, Ph.D.
    Add to my network

    Location

    Princeton, New Jersey, United States